Armenia vs Czechia: Cause of death, by non-communicable diseases, ages 60+
Armenia
74.2%
in 2021
Czechia
73.6%
in 2021
Armenia rank
77th
Czechia rank
79th
Cause of death, by non-communicable diseases, ages 60+ over time
- Armenia
- Czechia
How they compare
Armenia currently reports 74.2% against 73.6% in Czechia, a difference of 0.6%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Armenia ahead.
Armenia ranks 77th and Czechia ranks 79th of 185 countries.
Across the 3 decades both report, Armenia averaged higher in 2 and Czechia in 1.
Head to head by decade
| Decade | Armenia | Czechia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.3% | 93.6% | 3.7% | Armenia |
| 2010s | 93.9% | 91.6% | 2.3% | Armenia |
| 2020s | 76.7% | 78.2% | 1.6% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Armenia or Czechia?
- Armenia, at 74.2% against 73.6% in Czechia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Armenia and Czechia?
- 0.6%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Czechia?
- 6 years are reported by both, from 2000 to 2021.
- How do Armenia and Czechia rank globally for cause of death, by non-communicable diseases, ages 60+?
- Armenia ranks 77th and Czechia ranks 79th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.